Cleared Traditional

K102405 - INFUSION SET FOR POWERPICC SOLO 2 CATHETER

K102405 is an FDA 510(k) clearance for INFUSION SET FOR POWERPICC SOLO 2 CATHETER, manufactured by C.R. Bard, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 331-day FDA review.

K102405 · C.R. Bard, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
331d
Days
Class 2
Risk

K102405 is an FDA 510(k) clearance for the INFUSION SET FOR POWERPICC SOLO 2 CATHETER. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on July 21, 2011 after a review of 331 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all C.R. Bard, Inc. devices

FDA 510(k) Submission Details - K102405

510(k) Number K102405 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 2010
Decision Date July 21, 2011
Days to Decision 331 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
202d slower than avg
Panel avg: 129d · This submission: 331d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 737
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K102405.
VANISHPOINT BLOOD COLLECTION SET
K112512 · Retractable Technologies, Inc. · Oct 2011
CLEARLINK LUER ACTIVATED VALVE, CLEARLINK SYSTEM NON-DEHP CATHETER EXTENSION SETS
K112893 · Baxter Healthcare Corporation · Oct 2011
TRUECARE BIOMEDIX INTRAVASCULAR ADMINISTRATION SET, TRUECARE BIOMEDIX EXTENSION SET
K111351 · Us Infusion Dba Truecare Biomedix · Sep 2011
CENTURION PRESSURE INJECTABLE EXTENSION SET
K103562 · Centurion Medical Products Corporation · Jun 2011
SAFEPORT MANIFOLD (TM) (OR STOPCOCK)
K111016 · Elcam Medical Acal · Jun 2011
LIGHTY DD INFUSION SET
K110282 · Medx-Set, Ltd. · Apr 2011